Navigation Links
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
Date:11/11/2011

y of neuropsychological disorders such as MS.

"We are very pleased to announce the initiation of this new clinical trial that will evaluate our drug candidate Trimesta," said James S. Kuo, M.D., M.B.A., Adeona's CEO and President. "Results from the ongoing Phase II relapsing-remitting MS clinical trial and this new Phase II clinical trial for cognitive dysfunction in MS patients should provide results within the same time frame. Expanding the clinical development of Trimesta in the United States to include cognitive benefit should broaden the potential treatment options for women suffering from MS and should increase the economic opportunity for our drug candidate."

About Trimesta™ (oral estriol)

Trimesta is Adeona's proprietary drug candidate for the treatment of relapsing-remitting MS and for cognitive dysfunction, both in female patients. Estriol has been approved and marketed for more than 40 years throughout Europe and Asia for the treatment of post-menopausal hot flashes. It has never been approved in the United States by the Food and Drug Administration (FDA) for any indication.

On September 19, 2011, Adeona announced that the 150th patient has been enrolled in the randomized, double-blind, placebo-controlled, multi-center clinical trial of its Trimesta drug candidate for relapsing-remitting MS in women, per the original protocol. The Company also announced that Dr. Voskuhl had received funding to continue enrollment of an additional 10-20 patients at all 15 centers.

About Cognitive Dysfunction in Multiple Sclerosis

According to the National Multiple Sclerosis Society and the Multiple Sclerosis Society of Canada publication, Hold that Thought! Cognition and MS, it is fairly common for people with multiple sclerosis to complain of problems remembering things, finding the right words, concentrating on a task or something they are reading, or following a conversation. These are all cognitive sy
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces Second Quarter 2010 Profitability and Achievements
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona to Hold Annual Shareholder Meeting
7. Adeona Announces Third Quarter 2010 Financial Results and Achievements
8. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
9. Adeona to Present at OneMedForum San Francisco 2011 Conference
10. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
11. Adeona to Raise $4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  B. Braun ... clinician and environmental safety with products, services and ... will feature its innovative Outlook® 400ES and Space ... barcoding capabilities at the American Association of Critical-Care ... the Boston Convention Center. ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... ("OSI")  whose subsidiary companies include OMNIlife science®, Inc., Enztec, ... directors to their Board.  Guy Mayer ... as the Chairman of the Board of Directors ... join as a director. Before joining ...
(Date:5/20/2013)... ALEXANDRIA, Va. , May 20, 2013   ... B. Douglas Hoey , RPh, MBA issued the ... Hart Research Associates regarding Medicare Part D "preferred ... pharmacies from offering patients the plan,s lowest advertised co-payments: ... "Officials with Medicare and MedPAC , ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... Inc. (NYSE: HRC ) will release its fiscal ... company will host a webcast the following morning on Thursday, ... Earnings Release:   Hill-Rom,s Fiscal 2011 Third Quarter Earnings Release ... to the public after the close of the NYSE on ...
... N.J., June 29, 2011 Par Pharmaceutical Companies, Inc. ... of its branded division, Strativa Pharmaceuticals, as part of ... a workforce reduction of approximately 100.  The Company believes ... the near term. Patrick G. LePore, Chairman, ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast 2Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuticals, to Maximize Profitability 2
(Date:5/21/2013)... Healthcare Solutions, the parent company of ... that it was honored to receive the Catamaran ... Conferred annually, the Innovation Award recognizes a client ... edge programs that improves cost and/or quality outcomes. ... its clinical and IT solutions that have helped ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The producers of ... May air dates for Peterborough, Ontario, Canada. The area is ... spot for Canadians and Americans. It is located an hour ... rivers. Peterborough is located in the Kawartha Hills, home to ... adds economic stability to the area. Residents and visitors to ...
(Date:5/21/2013)... 21, 2013 It’s nearly summer and millions ... or starting practice for summer or fall sports. In ... sporting activities can begin. , To help parents during ... youth sports or camp physicals at just $29. ... review a child’s medical history, perform a physical exam and ...
(Date:5/21/2013)... 21, 2013 Dallas-based TopMD™ Skin Care ... article testing the efficacy of their flagship product, ... clinical study results appear in the May/June 2013 issue ... “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response and ... impressive findings seen after consistent use of the product ...
(Date:5/21/2013)... 2013 Dimensional Insight, a developer of ... Western Maryland Health System, a 275-bed hospital ... Solution™ (Diver) to help it analyze its data more ... to purchase Diver through Dimensional Insight’s recently announced ... hospitals, Western Maryland has massive amounts of data in ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3
... 3 Targeted Genetics Corporation,(Nasdaq: TGEN ) ... (NIH),Recombinant DNA Advisory Committee,s (RAC) assessment of the ... Phase I/II trial of,tgAAC94 for inflammatory arthritis., ... was a result of,complications from an opportunistic infection, ...
... ALBANY, N.Y., Dec. 3 AARP recently ... the state to,address three major issues that impact ... New Yorkers: prescription drug marketing reform and,affordability, housing ... are critical issues that help New Yorkers stay ...
... Dec. 3 Coherent, Inc.,(Nasdaq: COHR ) today ... of the Board of Directors of The Nasdaq Stock ... file its past due periodic reports,for the year ended ... 2007 with the Securities Exchange Commission ("SEC") in order ...
... ORLANDO, Fla., Dec. 3 A new study ... depressant effects in,patients (40 years and older) with ... measured by oxygenation or abnormal breathing,events relative to ... at the 53rd International,Respiratory Congress of the American ...
... that protect cells from the powerful, common chemotherapeutic agent ... how the drug also can destroy the heart., We ... for cell survival in the face of doxorubicin, says ... of Georgia Cancer Center. At the moment you start ...
... to lead can hinder the brains ability to recover ... The results have implications for the effects of environmental ... researchers at Jefferson Medical College, who led the work. ... increase the risk for cancer, renal disease, hypertension and ...
Cached Medicine News:Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 2Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 3Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 4Health News:AARP Urges Governor to Use Budget to Improve New Yorkers' Quality of Life 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 2Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 4Health News:Genes identified that protect against heart damage from chemotherapy 2Health News:Jefferson neuroscientists find early lead exposure impedes recovery from brain injury 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: